Cardinal Health stock slides 2.80% and underperforms rivals
Updated
Updated · MarketWatch · May 6
Cardinal Health stock slides 2.80% and underperforms rivals
8 articles · Updated · MarketWatch · May 6
Shares closed at $191.49 on Wednesday as the S&P 500 rose 1.46% and the Dow gained 1.24% in a broadly stronger market.
The stock fell for a second straight session and lagged Amazon, UnitedHealth and CVS, whose shares rose 0.53%, 0.94% and 7.65% respectively.
Cardinal Health ended 18.03% below its 52-week high of $233.60 reached on 2 March, while trading volume of 4.3 million topped its 50-day average of 1.8 million.
Cardinal Health beat earnings but its stock fell. Is its pivot to specialty drugs not enough for Wall Street?
The GLP-1 drug market is booming. Why did Cardinal Health report a moderation in this key growth area?
With strong buybacks but falling GAAP profits, what is the true financial health of this Dividend Aristocrat?